- Home
- ANEB vs MAPS Comparison
ANEB vs MAPS Comparison
Compare ANEB & MAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- MAPS
- Stock Information
- Founded
- ANEB 2020
- MAPS 2008
- Country
- ANEB United States
- MAPS United States
- Employees
- ANEB N/A
- MAPS N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- MAPS Computer Software: Prepackaged Software
- Sector
- ANEB Health Care
- MAPS Technology
- Exchange
- ANEB Nasdaq
- MAPS Nasdaq
- Market Cap
- ANEB 111.8M
- MAPS 127.3M
- IPO Year
- ANEB 2021
- MAPS N/A
- Fundamental
- Price
- ANEB $2.76
- MAPS $1.16
- Analyst Decision
- ANEB Buy
- MAPS Strong Buy
- Analyst Count
- ANEB 2
- MAPS 1
- Target Price
- ANEB $8.00
- MAPS $2.61
- AVG Volume (30 Days)
- ANEB 25.7K
- MAPS 1.5M
- Earning Date
- ANEB 11-12-2025
- MAPS 11-06-2025
- Dividend Yield
- ANEB N/A
- MAPS N/A
- EPS Growth
- ANEB N/A
- MAPS N/A
- EPS
- ANEB N/A
- MAPS 0.09
- Revenue
- ANEB N/A
- MAPS $183,681,000.00
- Revenue This Year
- ANEB N/A
- MAPS N/A
- Revenue Next Year
- ANEB N/A
- MAPS $5.43
- P/E Ratio
- ANEB N/A
- MAPS $13.75
- Revenue Growth
- ANEB N/A
- MAPS 0.13
- 52 Week Low
- ANEB $0.80
- MAPS $0.70
- 52 Week High
- ANEB $3.42
- MAPS $1.65
- Technical
- Relative Strength Index (RSI)
- ANEB 64.17
- MAPS 54.64
- Support Level
- ANEB $2.50
- MAPS $1.03
- Resistance Level
- ANEB $2.76
- MAPS $1.19
- Average True Range (ATR)
- ANEB 0.12
- MAPS 0.06
- MACD
- ANEB 0.03
- MAPS 0.00
- Stochastic Oscillator
- ANEB 85.00
- MAPS 69.76
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About MAPS WM Technology Inc.
WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises the B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on marketplace ads.